speb/financial-data huggingface dataset:
LEN balance_sheet (annual, 2024-11-30) — Share Issued: 296580668.00
LEN cash_flow (annual, 2024-11-30) — Stock Based Compensation: 176676000.00
LEN balance_sheet (annual, 2024-11-30) — Stockholders Equity: 27870135000.00
LEN balance_sheet (annual, 2024-11-30) — Tangible Book Value: 24238077000.00
LEN income_statement (annual, 2024-11-30) — Tax Effect Of Unusual Items: 5952552.00
LEN income_statement (annual, 2024-11-30) — Tax Provision: 1217253000.00
LEN income_statement (annual, 2024-11-30) — Tax Rate For Calcs: 0.24
LEN balance_sheet (annual, 2024-11-30) — Total Assets: 41312781000.00
LEN balance_sheet (annual, 2024-11-30) — Total Capitalization: 32059374000.00
LEN balance_sheet (annual, 2024-11-30) — Total Debt: 4189239000.00
LEN balance_sheet (annual, 2024-11-30) — Total Equity Gross Minority Interest: 28021225000.00
LEN income_statement (annual, 2024-11-30) — Total Expenses: 30591479000.00
LEN balance_sheet (annual, 2024-11-30) — Total Liabilities Net Minority Interest: 13291556000.00
LEN balance_sheet (annual, 2024-11-30) — Total Non Current Assets: 12005318000.00
LEN balance_sheet (annual, 2024-11-30) — Total Non Current Liabilities Net Minority Interest: 11452116000.00
LEN income_statement (annual, 2024-11-30) — Total Unusual Items: 25180000.00
LEN income_statement (annual, 2024-11-30) — Total Unusual Items Excluding Goodwill: 25180000.00
LEN balance_sheet (annual, 2024-11-30) — Tradeand Other Payables Non Current: 497391000.00
LEN balance_sheet (annual, 2024-11-30) — Treasury Shares Number: 28346849.00
LEN balance_sheet (annual, 2024-11-30) — Treasury Stock: 3649564000.00
LEN cash_flow (annual, 2024-11-30) — Unrealized Gain Loss On Investment Securities: -67226000.00
LEN cash_flow (quarterly, 2024-11-30) — Unrealized Gain Loss On Investment Securities: -157814000.00
LEN balance_sheet (annual, 2024-11-30) — Working Capital: 27468023000.00
LEN income_statement (quarterly, 2025-02-28) — +Operating Expense: 147378000.00
LEN income_statement (quarterly, 2025-02-28) — +Total Revenue: 7631545000.00
LEN balance_sheet (quarterly, 2025-02-28) — Accounts Payable: 1926358000.00
LEN balance_sheet (quarterly, 2025-02-28) — Accounts Receivable: 1533608000.00
LEN balance_sheet (quarterly, 2025-02-28) — Additional Paid In Capital: 5812802000.00
LEN balance_sheet (quarterly, 2025-02-28) — Available For Sale Securities: 245628000.00
LEN income_statement (quarterly, 2025-02-28) — Basic Average Shares: 262733000.00
LEN income_statement (quarterly, 2025-02-28) — Basic EPS: 1.96
LEN cash_flow (quarterly, 2025-02-28) — Beginning Cash Position: 4990210000.00
LEN cash_flow (quarterly, 2025-02-28) — Capital Expenditure: -56043000.00
LEN balance_sheet (quarterly, 2025-02-28) — Capital Stock: 29793000.00
LEN balance_sheet (quarterly, 2025-02-28) — Cash And Cash Equivalents: 2516772000.00
LEN balance_sheet (quarterly, 2025-02-28) — Cash Cash Equivalents And Short Term Investments: 2557173000.00
LEN cash_flow (quarterly, 2025-02-28) — Cash Dividends Paid: -131646000.00
LEN cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Financing Activities: -2134643000.00
LEN cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Investing Activities: 21490000.00
LEN cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Operating Activities: -289042000.00
LEN cash_flow (quarterly, 2025-02-28) — Change In Account Payable: -215035000.00
LEN cash_flow (quarterly, 2025-02-28) — Change In Inventory: -513257000.00
LEN cash_flow (quarterly, 2025-02-28) — Change In Other Current Assets: -57501000.00
LEN cash_flow (quarterly, 2025-02-28) — Change In Payable: -215035000.00
LEN cash_flow (quarterly, 2025-02-28) — Change In Payables And Accrued Expense: -215035000.00
LEN cash_flow (quarterly, 2025-02-28) — Change In Prepaid Assets: -757972000.00
LEN cash_flow (quarterly, 2025-02-28) — Change In Receivables: 562986000.00
LEN cash_flow (quarterly, 2025-02-28) — Change In Working Capital: -980779000.00
LEN cash_flow (quarterly, 2025-02-28) — Changes In Account Receivables: 117753000.00
LEN cash_flow (quarterly, 2025-02-28) — Changes In Cash: -2402195000.00
LEN balance_sheet (quarterly, 2025-02-28) — Common Stock: 29793000.00
LEN cash_flow (quarterly, 2025-02-28) — Common Stock Dividend Paid: -131646000.00
LEN balance_sheet (quarterly, 2025-02-28) — Common Stock Equity: 22728038000.00
LEN cash_flow (quarterly, 2025-02-28) — Common Stock Payments: -774475000.00
LEN balance_sheet (quarterly, 2025-02-28) — Construction In Progress: 5172084000.00
LEN income_statement (quarterly, 2025-02-28) — Cost Of Revenue: 6770494000.00
LEN balance_sheet (quarterly, 2025-02-28) — Current Assets: 20302525000.00
LEN balance_sheet (quarterly, 2025-02-28) — Current Liabilities: 1926358000.00
LEN cash_flow (quarterly, 2025-02-28) — Deferred Income Tax: 23472000.00
LEN cash_flow (quarterly, 2025-02-28) — Deferred Tax: 23472000.00
LEN cash_flow (quarterly, 2025-02-28) — Depreciation Amortization Depletion: 31332000.00
LEN cash_flow (quarterly, 2025-02-28) — Depreciation And Amortization: 31332000.00
LEN income_statement (quarterly, 2025-02-28) — Diluted Average Shares: 262733000.00
LEN income_statement (quarterly, 2025-02-28) — Diluted EPS: 1.96
LEN income_statement (quarterly, 2025-02-28) — Diluted NI Availto Com Stockholders: 514709000.00
LEN cash_flow (quarterly, 2025-02-28) — Dividend Received Cfo: 11586000.00
LEN cash_flow (quarterly, 2025-02-28) — Dividends Received Cfi: 35455000.00
LEN income_statement (quarterly, 2025-02-28) — EBIT: 713673000.00
LEN income_statement (quarterly, 2025-02-28) — EBITDA: 745005000.00
LEN income_statement (quarterly, 2025-02-28) — Earnings From Equity Interest: 33234000.00
LEN cash_flow (quarterly, 2025-02-28) — Earnings Losses From Equity Investments: -33234000.00
LEN cash_flow (quarterly, 2025-02-28) — End Cash Position: 2588015000.00
LEN cash_flow (quarterly, 2025-02-28) — Financing Cash Flow: -2134643000.00
LEN balance_sheet (quarterly, 2025-02-28) — Finished Goods: 10154074000.00
LEN cash_flow (quarterly, 2025-02-28) — Free Cash Flow: -345085000.00
LEN cash_flow (quarterly, 2025-02-28) — Gain Loss On Investment Securities: 28261000.00
LEN income_statement (quarterly, 2025-02-28) — Gain On Sale Of Security: -62503000.00
LEN balance_sheet (quarterly, 2025-02-28) — Gains Losses Not Affecting Retained Earnings: 7351000.00
LEN income_statement (quarterly, 2025-02-28) — General And Administrative Expense: 147378000.00
LEN balance_sheet (quarterly, 2025-02-28) — Goodwill: 3632058000.00
LEN balance_sheet (quarterly, 2025-02-28) — Goodwill And Other Intangible Assets: 3632058000.00
LEN balance_sheet (quarterly, 2025-02-28) — Gross PPE: 5172084000.00
LEN income_statement (quarterly, 2025-02-28) — Gross Profit: 861051000.00
LEN balance_sheet (quarterly, 2025-02-28) — Held To Maturity Securities: 134369000.00
LEN balance_sheet (quarterly, 2025-02-28) — Inventory: 14251930000.00
LEN balance_sheet (quarterly, 2025-02-28) — Invested Capital: 26336435000.00
LEN cash_flow (quarterly, 2025-02-28) — Investing Cash Flow: 21490000.00
LEN balance_sheet (quarterly, 2025-02-28) — Investmentin Financial Assets: 379997000.00
LEN balance_sheet (quarterly, 2025-02-28) — Investments And Advances: 3873792000.00
LEN balance_sheet (quarterly, 2025-02-28) — Investments In Other Ventures Under Equity Method: 3493795000.00
LEN cash_flow (quarterly, 2025-02-28) — Issuance Of Debt: 0.00
LEN balance_sheet (quarterly, 2025-02-28) — Loans Receivable: 1888571000.00
LEN balance_sheet (quarterly, 2025-02-28) — Long Term Debt: 3608397000.00
LEN balance_sheet (quarterly, 2025-02-28) — Long Term Debt And Capital Lease Obligation: 3608397000.00
LEN cash_flow (quarterly, 2025-02-28) — Long Term Debt Issuance: 0.00
LEN cash_flow (quarterly, 2025-02-28) — Long Term Debt Payments: -27600000.00
LEN balance_sheet (quarterly, 2025-02-28) — Long Term Equity Investment: 3493795000.00
LEN balance_sheet (quarterly, 2025-02-28) — Minority Interest: 139306000.00
LEN income_statement (quarterly, 2025-02-28) — Minority Interests: -9187000.00
LEN cash_flow (quarterly, 2025-02-28) — Net Business Purchase And Sale: -77128000.00
LEN cash_flow (quarterly, 2025-02-28) — Net Common Stock Issuance: -774475000.00
LEN balance_sheet (quarterly, 2025-02-28) — Net Debt: 1091625000.00
LEN income_statement (quarterly, 2025-02-28) — Net Income: 519526000.00
LEN income_statement (quarterly, 2025-02-28) — Net Income Common Stockholders: 514709000.00
LEN income_statement (quarterly, 2025-02-28) — Net Income Continuous Operations: 528713000.00
LEN income_statement (quarterly, 2025-02-28) — Net Income From Continuing And Discontinued Operation: 519526000.00
LEN income_statement (quarterly, 2025-02-28) — Net Income From Continuing Operation Net Minority Interest: 519526000.00
LEN cash_flow (quarterly, 2025-02-28) — Net Income From Continuing Operations: 528713000.00
LEN income_statement (quarterly, 2025-02-28) — Net Income Including Noncontrolling Interests: 528713000.00
LEN cash_flow (quarterly, 2025-02-28) — Net Investment Purchase And Sale: 70481000.00
LEN cash_flow (quarterly, 2025-02-28) — Net Issuance Payments Of Debt: -561431000.00
LEN cash_flow (quarterly, 2025-02-28) — Net Long Term Debt Issuance: -27600000.00
LEN cash_flow (quarterly, 2025-02-28) — Net Other Financing Charges: -667091000.00
LEN cash_flow (quarterly, 2025-02-28) — Net Other Investing Changes: 48725000.00
LEN balance_sheet (quarterly, 2025-02-28) — Net PPE: 5172084000.00
LEN cash_flow (quarterly, 2025-02-28) — Net PPE Purchase And Sale: -56043000.00
LEN cash_flow (quarterly, 2025-02-28) — Net Short Term Debt Issuance: -533831000.00
LEN balance_sheet (quarterly, 2025-02-28) — Net Tangible Assets: 19095980000.00
LEN income_statement (quarterly, 2025-02-28) — Normalized EBITDA: 807508000.00
LEN income_statement (quarterly, 2025-02-28) — Normalized Income: 566853914.89
LEN cash_flow (quarterly, 2025-02-28) — Operating Cash Flow: -289042000.00
LEN cash_flow (quarterly, 2025-02-28) — Operating Gains Losses: -28384000.00
LEN income_statement (quarterly, 2025-02-28) — Operating Income: 713673000.00
LEN income_statement (quarterly, 2025-02-28) — Operating Revenue: 7631545000.00
LEN balance_sheet (quarterly, 2025-02-28) — Ordinary Shares Number: 263794179.00
LEN balance_sheet (quarterly, 2025-02-28) — Other Equity Adjustments: 7351000.00
LEN income_statement (quarterly, 2025-02-28) — Other Gand A: 147378000.00
LEN income_statement (quarterly, 2025-02-28) — Other Income Expense: -15435000.00
LEN balance_sheet (quarterly, 2025-02-28) — Other Inventories: 4097856000.00
LEN cash_flow (quarterly, 2025-02-28) — Other Non Cash Items: 40933000.00
LEN balance_sheet (quarterly, 2025-02-28) — Other Non Current Assets: 2005644000.00
LEN balance_sheet (quarterly, 2025-02-28) — Other Non Current Liabilities: 6113861000.00
LEN income_statement (quarterly, 2025-02-28) — Other Non Operating Income Expenses: 13834000.00
LEN balance_sheet (quarterly, 2025-02-28) — Other Short Term Investments: 40401000.00
LEN income_statement (quarterly, 2025-02-28) — Otherunder Preferred Stock Dividend: 4817000.00
LEN balance_sheet (quarterly, 2025-02-28) — Payables: 1926358000.00
LEN balance_sheet (quarterly, 2025-02-28) — Payables And Accrued Expenses: 1926358000.00
LEN balance_sheet (quarterly, 2025-02-28) — Preferred Stock: 0.00
LEN income_statement (quarterly, 2025-02-28) — Pretax Income: 698238000.00
LEN cash_flow (quarterly, 2025-02-28) — Purchase Of Business: -310135000.00
LEN cash_flow (quarterly, 2025-02-28) — Purchase Of Investment: -3456000.00
LEN cash_flow (quarterly, 2025-02-28) — Purchase Of PPE: -56043000.00
LEN balance_sheet (quarterly, 2025-02-28) — Receivables: 3422179000.00
LEN income_statement (quarterly, 2025-02-28) — Reconciled Cost Of Revenue: 6770494000.00
LEN income_statement (quarterly, 2025-02-28) — Reconciled Depreciation: 31332000.00
LEN cash_flow (quarterly, 2025-02-28) — Repayment Of Debt: -561431000.00
LEN cash_flow (quarterly, 2025-02-28) — Repurchase Of Capital Stock: -774475000.00
LEN balance_sheet (quarterly, 2025-02-28) — Restricted Cash: 71243000.00
LEN balance_sheet (quarterly, 2025-02-28) — Retained Earnings: 21302131000.00
LEN cash_flow (quarterly, 2025-02-28) — Sale Of Business: 233007000.00
LEN cash_flow (quarterly, 2025-02-28) — Sale Of Investment: 73937000.00
LEN income_statement (quarterly, 2025-02-28) — Selling General And Administration: 147378000.00
LEN balance_sheet (quarterly, 2025-02-28) — Share Issued: 297932116.00
LEN cash_flow (quarterly, 2025-02-28) — Short Term Debt Payments: -533831000.00
LEN cash_flow (quarterly, 2025-02-28) — Stock Based Compensation: 84085000.00
LEN balance_sheet (quarterly, 2025-02-28) — Stockholders Equity: 22728038000.00
LEN balance_sheet (quarterly, 2025-02-28) — Tangible Book Value: 19095980000.00
LEN income_statement (quarterly, 2025-02-28) — Tax Effect Of Unusual Items: -15175085.11
LEN income_statement (quarterly, 2025-02-28) — Tax Provision: 169525000.00
LEN income_statement (quarterly, 2025-02-28) — Tax Rate For Calcs: 0.24
LEN balance_sheet (quarterly, 2025-02-28) — Total Assets: 34986103000.00
LEN balance_sheet (quarterly, 2025-02-28) — Total Capitalization: 26336435000.00
LEN balance_sheet (quarterly, 2025-02-28) — Total Debt: 3608397000.00
LEN balance_sheet (quarterly, 2025-02-28) — Total Equity Gross Minority Interest: 22867344000.00
LEN income_statement (quarterly, 2025-02-28) — Total Expenses: 6917872000.00
LEN balance_sheet (quarterly, 2025-02-28) — Total Liabilities Net Minority Interest: 12118759000.00
LEN balance_sheet (quarterly, 2025-02-28) — Total Non Current Assets: 14683578000.00
LEN balance_sheet (quarterly, 2025-02-28) — Total Non Current Liabilities Net Minority Interest: 10192401000.00
LEN income_statement (quarterly, 2025-02-28) — Total Unusual Items: -62503000.00
LEN income_statement (quarterly, 2025-02-28) — Total Unusual Items Excluding Goodwill: -62503000.00
LEN balance_sheet (quarterly, 2025-02-28) — Tradeand Other Payables Non Current: 470143000.00
LEN balance_sheet (quarterly, 2025-02-28) — Treasury Shares Number: 34137937.00
LEN balance_sheet (quarterly, 2025-02-28) — Treasury Stock: 4424039000.00
LEN balance_sheet (quarterly, 2025-02-28) — Working Capital: 18376167000.00
LEN income_statement (quarterly, 2025-05-31) — +Operating Expense: 155853000.00
LEN income_statement (quarterly, 2025-05-31) — +Total Revenue: 8377502000.00
LEN balance_sheet (quarterly, 2025-05-31) — Accounts Payable: 2126002000.00
LEN balance_sheet (quarterly, 2025-05-31) — Accounts Receivable: 1470743000.00
LEN balance_sheet (quarterly, 2025-05-31) — Additional Paid In Capital: 5842732000.00
LEN balance_sheet (quarterly, 2025-05-31) — Available For Sale Securities: 216188000.00
LEN income_statement (quarterly, 2025-05-31) — Basic Average Shares: 260286000.00
LEN income_statement (quarterly, 2025-05-31) — Basic EPS: 1.81
LEN cash_flow (quarterly, 2025-05-31) — Beginning Cash Position: 2588015000.00
LEN cash_flow (quarterly, 2025-05-31) — Capital Expenditure: -15216000.00
LEN balance_sheet (quarterly, 2025-05-31) — Capital Stock: 29796000.00
LEN balance_sheet (quarterly, 2025-05-31) — Cash And Cash Equivalents: 1407694000.00
LEN balance_sheet (quarterly, 2025-05-31) — Cash Cash Equivalents And Short Term Investments: 1446763000.00
LEN cash_flow (quarterly, 2025-05-31) — Cash Dividends Paid: -133589000.00
LEN cash_flow (quarterly, 2025-05-31) — Cash Flow From Continuing Financing Activities: -175369000.00
LEN cash_flow (quarterly, 2025-05-31) — Cash Flow From Continuing Investing Activities: 161391000.00
LEN cash_flow (quarterly, 2025-05-31) — Cash Flow From Continuing Operating Activities: -1095022000.00
LEN cash_flow (quarterly, 2025-05-31) — Change In Account Payable: -384991000.00
LEN cash_flow (quarterly, 2025-05-31) — Change In Inventory: -1111329000.00
LEN cash_flow (quarterly, 2025-05-31) — Change In Other Current Assets: 286207000.00
LEN cash_flow (quarterly, 2025-05-31) — Change In Payable: -384991000.00
LEN cash_flow (quarterly, 2025-05-31) — Change In Payables And Accrued Expense: -384991000.00
LEN cash_flow (quarterly, 2025-05-31) — Change In Prepaid Assets: -23744000.00
LEN cash_flow (quarterly, 2025-05-31) — Change In Receivables: -493387000.00
LEN cash_flow (quarterly, 2025-05-31) — Change In Working Capital: -1727244000.00
LEN cash_flow (quarterly, 2025-05-31) — Changes In Cash: -1109000000.00
LEN balance_sheet (quarterly, 2025-05-31) — Common Stock: 29796000.00
LEN cash_flow (quarterly, 2025-05-31) — Common Stock Dividend Paid: -133589000.00
LEN balance_sheet (quarterly, 2025-05-31) — Common Stock Equity: 22579080000.00
LEN cash_flow (quarterly, 2025-05-31) — Common Stock Payments: -521419000.00
LEN balance_sheet (quarterly, 2025-05-31) — Construction In Progress: 13965000.00
LEN income_statement (quarterly, 2025-05-31) — Cost Of Revenue: 7573072000.00
LEN balance_sheet (quarterly, 2025-05-31) — Current Assets: 19445116000.00
LEN balance_sheet (quarterly, 2025-05-31) — Current Liabilities: 2126002000.00
LEN cash_flow (quarterly, 2025-05-31) — Deferred Income Tax: 14909000.00
LEN cash_flow (quarterly, 2025-05-31) — Deferred Tax: 14909000.00
LEN cash_flow (quarterly, 2025-05-31) — Depreciation Amortization Depletion: 33825000.00
LEN cash_flow (quarterly, 2025-05-31) — Depreciation And Amortization: 33825000.00
LEN income_statement (quarterly, 2025-05-31) — Diluted Average Shares: 260286000.00
LEN income_statement (quarterly, 2025-05-31) — Diluted EPS: 1.81
LEN income_statement (quarterly, 2025-05-31) — Diluted NI Availto Com Stockholders: 471172000.00
LEN cash_flow (quarterly, 2025-05-31) — Dividend Received Cfo: 8484000.00
LEN cash_flow (quarterly, 2025-05-31) — Dividends Received Cfi: 139748000.00
LEN income_statement (quarterly, 2025-05-31) — EBIT: 648577000.00
LEN income_statement (quarterly, 2025-05-31) — EBITDA: 682402000.00
LEN income_statement (quarterly, 2025-05-31) — Earnings From Equity Interest: 12116000.00
LEN cash_flow (quarterly, 2025-05-31) — Earnings Losses From Equity Investments: -12117000.00
LEN cash_flow (quarterly, 2025-05-31) — End Cash Position: 1479015000.00
LEN cash_flow (quarterly, 2025-05-31) — Financing Cash Flow: -175369000.00
LEN balance_sheet (quarterly, 2025-05-31) — Finished Goods: 11375461000.00
LEN cash_flow (quarterly, 2025-05-31) — Free Cash Flow: -1110238000.00
LEN cash_flow (quarterly, 2025-05-31) — Gain Loss On Investment Securities: 61466000.00
LEN income_statement (quarterly, 2025-05-31) — Gain On Sale Of Security: -29440000.00
LEN balance_sheet (quarterly, 2025-05-31) — Gains Losses Not Affecting Retained Earnings: 6019000.00
LEN income_statement (quarterly, 2025-05-31) — General And Administrative Expense: 155853000.00
LEN balance_sheet (quarterly, 2025-05-31) — Goodwill: 3632058000.00
LEN balance_sheet (quarterly, 2025-05-31) — Goodwill And Other Intangible Assets: 3632058000.00
LEN balance_sheet (quarterly, 2025-05-31) — Gross PPE: 13965000.00
LEN income_statement (quarterly, 2025-05-31) — Gross Profit: 804430000.00
LEN balance_sheet (quarterly, 2025-05-31) — Held To Maturity Securities: 134280000.00
LEN balance_sheet (quarterly, 2025-05-31) — Inventory: 14516800000.00
LEN balance_sheet (quarterly, 2025-05-31) — Invested Capital: 26787205000.00
LEN cash_flow (quarterly, 2025-05-31) — Investing Cash Flow: 161391000.00
LEN balance_sheet (quarterly, 2025-05-31) — Investment Properties: 5265591000.00
LEN balance_sheet (quarterly, 2025-05-31) — Investmentin Financial Assets: 350468000.00
LEN balance_sheet (quarterly, 2025-05-31) — Investments And Advances: 3939697000.00
LEN balance_sheet (quarterly, 2025-05-31) — Investments In Other Ventures Under Equity Method: 3589229000.00
LEN cash_flow (quarterly, 2025-05-31) — Issuance Of Debt: 1100000000.00
LEN balance_sheet (quarterly, 2025-05-31) — Loans Receivable: 1939489000.00
LEN balance_sheet (quarterly, 2025-05-31) — Long Term Debt: 4208125000.00
LEN balance_sheet (quarterly, 2025-05-31) — Long Term Debt And Capital Lease Obligation: 4208125000.00
LEN cash_flow (quarterly, 2025-05-31) — Long Term Debt Issuance: 1100000000.00
LEN cash_flow (quarterly, 2025-05-31) — Long Term Debt Payments: -512729000.00
LEN balance_sheet (quarterly, 2025-05-31) — Long Term Equity Investment: 3589229000.00
LEN balance_sheet (quarterly, 2025-05-31) — Minority Interest: 152802000.00
LEN income_statement (quarterly, 2025-05-31) — Minority Interests: -4371000.00
LEN cash_flow (quarterly, 2025-05-31) — Net Business Purchase And Sale: -89851000.00
LEN cash_flow (quarterly, 2025-05-31) — Net Common Stock Issuance: -521419000.00
LEN balance_sheet (quarterly, 2025-05-31) — Net Debt: 2800431000.00
LEN income_statement (quarterly, 2025-05-31) — Net Income: 477449000.00
LEN income_statement (quarterly, 2025-05-31) — Net Income Common Stockholders: 471172000.00
LEN income_statement (quarterly, 2025-05-31) — Net Income Continuous Operations: 481820000.00
LEN income_statement (quarterly, 2025-05-31) — Net Income From Continuing And Discontinued Operation: 477449000.00
LEN income_statement (quarterly, 2025-05-31) — Net Income From Continuing Operation Net Minority Interest: 477449000.00
LEN cash_flow (quarterly, 2025-05-31) — Net Income From Continuing Operations: 481820000.00
LEN income_statement (quarterly, 2025-05-31) — Net Income Including Noncontrolling Interests: 481820000.00
LEN cash_flow (quarterly, 2025-05-31) — Net Investment Purchase And Sale: 612000.00
LEN cash_flow (quarterly, 2025-05-31) — Net Issuance Payments Of Debt: 606284000.00
LEN cash_flow (quarterly, 2025-05-31) — Net Long Term Debt Issuance: 587271000.00
LEN cash_flow (quarterly, 2025-05-31) — Net Other Financing Charges: -126645000.00
LEN cash_flow (quarterly, 2025-05-31) — Net Other Investing Changes: 126098000.00
LEN balance_sheet (quarterly, 2025-05-31) — Net PPE: 13965000.00
LEN cash_flow (quarterly, 2025-05-31) — Net PPE Purchase And Sale: -15216000.00
LEN cash_flow (quarterly, 2025-05-31) — Net Short Term Debt Issuance: 19013000.00
LEN balance_sheet (quarterly, 2025-05-31) — Net Tangible Assets: 18947022000.00
LEN income_statement (quarterly, 2025-05-31) — Normalized EBITDA: 711842000.00
LEN income_statement (quarterly, 2025-05-31) — Normalized Income: 499499560.00
LEN cash_flow (quarterly, 2025-05-31) — Operating Cash Flow: -1095022000.00
LEN cash_flow (quarterly, 2025-05-31) — Operating Gains Losses: 3130000.00
LEN income_statement (quarterly, 2025-05-31) — Operating Income: 648577000.00
LEN income_statement (quarterly, 2025-05-31) — Operating Revenue: 8377502000.00
LEN balance_sheet (quarterly, 2025-05-31) — Ordinary Shares Number: 259006833.00
LEN balance_sheet (quarterly, 2025-05-31) — Other Equity Adjustments: 6019000.00
LEN income_statement (quarterly, 2025-05-31) — Other Gand A: 155853000.00
LEN income_statement (quarterly, 2025-05-31) — Other Income Expense: -6696000.00
LEN balance_sheet (quarterly, 2025-05-31) — Other Inventories: 3141339000.00
LEN cash_flow (quarterly, 2025-05-31) — Other Non Cash Items: -38725000.00
LEN balance_sheet (quarterly, 2025-05-31) — Other Non Current Assets: 2078119000.00
LEN balance_sheet (quarterly, 2025-05-31) — Other Non Current Liabilities: 4902493000.00
LEN income_statement (quarterly, 2025-05-31) — Other Non Operating Income Expenses: 10628000.00
LEN balance_sheet (quarterly, 2025-05-31) — Other Short Term Investments: 39069000.00
LEN income_statement (quarterly, 2025-05-31) — Otherunder Preferred Stock Dividend: 6277000.00
LEN balance_sheet (quarterly, 2025-05-31) — Payables: 2126002000.00
LEN balance_sheet (quarterly, 2025-05-31) — Payables And Accrued Expenses: 2126002000.00
LEN balance_sheet (quarterly, 2025-05-31) — Preferred Stock: 0.00
LEN income_statement (quarterly, 2025-05-31) — Pretax Income: 641881000.00
LEN cash_flow (quarterly, 2025-05-31) — Purchase Of Business: -89851000.00
LEN cash_flow (quarterly, 2025-05-31) — Purchase Of Investment: 0.00
LEN cash_flow (quarterly, 2025-05-31) — Purchase Of PPE: -15216000.00
LEN balance_sheet (quarterly, 2025-05-31) — Receivables: 3410232000.00
LEN income_statement (quarterly, 2025-05-31) — Reconciled Cost Of Revenue: 7573072000.00
LEN income_statement (quarterly, 2025-05-31) — Reconciled Depreciation: 33825000.00
LEN cash_flow (quarterly, 2025-05-31) — Repayment Of Debt: -493716000.00
LEN cash_flow (quarterly, 2025-05-31) — Repurchase Of Capital Stock: -521419000.00
LEN balance_sheet (quarterly, 2025-05-31) — Restricted Cash: 71321000.00
LEN balance_sheet (quarterly, 2025-05-31) — Retained Earnings: 21645991000.00
LEN cash_flow (quarterly, 2025-05-31) — Sale Of Business: 0.00
LEN cash_flow (quarterly, 2025-05-31) — Sale Of Investment: 612000.00
LEN income_statement (quarterly, 2025-05-31) — Selling General And Administration: 155853000.00
LEN balance_sheet (quarterly, 2025-05-31) — Share Issued: 297957073.00
LEN cash_flow (quarterly, 2025-05-31) — Short Term Debt Payments: 19013000.00
LEN cash_flow (quarterly, 2025-05-31) — Stock Based Compensation: 28773000.00
LEN balance_sheet (quarterly, 2025-05-31) — Stockholders Equity: 22579080000.00
LEN balance_sheet (quarterly, 2025-05-31) — Tangible Book Value: 18947022000.00
LEN income_statement (quarterly, 2025-05-31) — Tax Effect Of Unusual Items: -7389440.00
LEN income_statement (quarterly, 2025-05-31) — Tax Provision: 160061000.00
LEN income_statement (quarterly, 2025-05-31) — Tax Rate For Calcs: 0.25
LEN balance_sheet (quarterly, 2025-05-31) — Total Assets: 34374546000.00
LEN balance_sheet (quarterly, 2025-05-31) — Total Capitalization: 26787205000.00
LEN balance_sheet (quarterly, 2025-05-31) — Total Debt: 4208125000.00
LEN balance_sheet (quarterly, 2025-05-31) — Total Equity Gross Minority Interest: 22731882000.00
LEN income_statement (quarterly, 2025-05-31) — Total Expenses: 7728925000.00
LEN balance_sheet (quarterly, 2025-05-31) — Total Liabilities Net Minority Interest: 11642664000.00
LEN balance_sheet (quarterly, 2025-05-31) — Total Non Current Assets: 14929430000.00
LEN balance_sheet (quarterly, 2025-05-31) — Total Non Current Liabilities Net Minority Interest: 9516662000.00
LEN income_statement (quarterly, 2025-05-31) — Total Unusual Items: -29440000.00
LEN income_statement (quarterly, 2025-05-31) — Total Unusual Items Excluding Goodwill: -29440000.00
LEN balance_sheet (quarterly, 2025-05-31) — Tradeand Other Payables Non Current: 406044000.00
LEN balance_sheet (quarterly, 2025-05-31) — Treasury Shares Number: 38950240.00
LEN balance_sheet (quarterly, 2025-05-31) — Treasury Stock: 4945458000.00
LEN balance_sheet (quarterly, 2025-05-31) — Working Capital: 17319114000.00
LEN income_statement (quarterly, 2025-08-31) — +Operating Expense: 171397000.00
LEN income_statement (quarterly, 2025-08-31) — +Total Revenue: 8810278000.00
LEN balance_sheet (quarterly, 2025-08-31) — Accounts Payable: 1521244000.00
LEN balance_sheet (quarterly, 2025-08-31) — Accounts Receivable: 1550283000.00
LEN balance_sheet (quarterly, 2025-08-31) — Additional Paid In Capital: 5884528000.00
LEN balance_sheet (quarterly, 2025-08-31) — Available For Sale Securities: 285589000.00
LEN income_statement (quarterly, 2025-08-31) — Basic Average Shares: 255601000.00
LEN income_statement (quarterly, 2025-08-31) — Basic EPS: 2.29
LEN cash_flow (quarterly, 2025-08-31) — Beginning Cash Position: 1479015000.00
LEN cash_flow (quarterly, 2025-08-31) — Capital Expenditure: -32165000.00
LEN balance_sheet (quarterly, 2025-08-31) — Capital Stock: 29813000.00
LEN balance_sheet (quarterly, 2025-08-31) — Cash And Cash Equivalents: 1662213000.00
LEN balance_sheet (quarterly, 2025-08-31) — Cash Cash Equivalents And Short Term Investments: 1701282000.00
LEN cash_flow (quarterly, 2025-08-31) — Cash Dividends Paid: -129122000.00
LEN cash_flow (quarterly, 2025-08-31) — Cash Flow From Continuing Financing Activities: 443840000.00
LEN cash_flow (quarterly, 2025-08-31) — Cash Flow From Continuing Investing Activities: -7247000.00
LEN cash_flow (quarterly, 2025-08-31) — Cash Flow From Continuing Operating Activities: -158611000.00
LEN cash_flow (quarterly, 2025-08-31) — Change In Account Payable: -378022000.00
LEN cash_flow (quarterly, 2025-08-31) — Change In Inventory: 309653000.00
LEN cash_flow (quarterly, 2025-08-31) — Change In Other Current Assets: -438598000.00
LEN cash_flow (quarterly, 2025-08-31) — Change In Payable: -378022000.00
LEN cash_flow (quarterly, 2025-08-31) — Change In Payables And Accrued Expense: -378022000.00
LEN cash_flow (quarterly, 2025-08-31) — Change In Prepaid Assets: -466674000.00
LEN cash_flow (quarterly, 2025-08-31) — Change In Receivables: 160509000.00
LEN cash_flow (quarterly, 2025-08-31) — Change In Working Capital: -813132000.00
LEN cash_flow (quarterly, 2025-08-31) — Changes In Cash: 277982000.00
LEN balance_sheet (quarterly, 2025-08-31) — Common Stock: 29813000.00
LEN cash_flow (quarterly, 2025-08-31) — Common Stock Dividend Paid: -129122000.00
LEN balance_sheet (quarterly, 2025-08-31) — Common Stock Equity: 22570320000.00
LEN cash_flow (quarterly, 2025-08-31) — Common Stock Payments: -512418000.00
LEN balance_sheet (quarterly, 2025-08-31) — Construction In Progress: 15425000.00
LEN income_statement (quarterly, 2025-08-31) — Cost Of Revenue: 7917683000.00
LEN balance_sheet (quarterly, 2025-08-31) — Current Assets: 19128133000.00
LEN balance_sheet (quarterly, 2025-08-31) — Current Liabilities: 1521244000.00
LEN cash_flow (quarterly, 2025-08-31) — Deferred Income Tax: 38951000.00
LEN cash_flow (quarterly, 2025-08-31) — Deferred Tax: 38951000.00
LEN cash_flow (quarterly, 2025-08-31) — Depreciation Amortization Depletion: 34169000.00
LEN cash_flow (quarterly, 2025-08-31) — Depreciation And Amortization: 34169000.00
LEN income_statement (quarterly, 2025-08-31) — Diluted Average Shares: 255601000.00
LEN income_statement (quarterly, 2025-08-31) — Diluted EPS: 2.29
LEN income_statement (quarterly, 2025-08-31) — Diluted NI Availto Com Stockholders: 585719000.00
LEN cash_flow (quarterly, 2025-08-31) — Dividend Received Cfo: 8196000.00
LEN cash_flow (quarterly, 2025-08-31) — Dividends Received Cfi: 60390000.00
LEN income_statement (quarterly, 2025-08-31) — EBIT: 721198000.00
LEN income_statement (quarterly, 2025-08-31) — EBITDA: 755367000.00
LEN income_statement (quarterly, 2025-08-31) — Earnings From Equity Interest: 10822000.00
LEN cash_flow (quarterly, 2025-08-31) — Earnings Losses From Equity Investments: -10821000.00
LEN cash_flow (quarterly, 2025-08-31) — End Cash Position: 1756997000.00
LEN cash_flow (quarterly, 2025-08-31) — Financing Cash Flow: 443840000.00
LEN balance_sheet (quarterly, 2025-08-31) — Finished Goods: 11119086000.00
LEN cash_flow (quarterly, 2025-08-31) — Free Cash Flow: -190776000.00
LEN cash_flow (quarterly, 2025-08-31) — Gain Loss On Investment Securities: -100020000.00
LEN cash_flow (quarterly, 2025-08-31) — Gain Loss On Sale Of Business: -645000.00
LEN income_statement (quarterly, 2025-08-31) — Gain On Sale Of Security: 99223000.00
LEN balance_sheet (quarterly, 2025-08-31) — Gains Losses Not Affecting Retained Earnings: 6019000.00
LEN income_statement (quarterly, 2025-08-31) — General And Administrative Expense: 171397000.00
LEN balance_sheet (quarterly, 2025-08-31) — Goodwill: 3632058000.00
LEN balance_sheet (quarterly, 2025-08-31) — Goodwill And Other Intangible Assets: 3632058000.00
LEN balance_sheet (quarterly, 2025-08-31) — Gross PPE: 15425000.00
LEN income_statement (quarterly, 2025-08-31) — Gross Profit: 892595000.00
LEN balance_sheet (quarterly, 2025-08-31) — Held To Maturity Securities: 133558000.00
LEN balance_sheet (quarterly, 2025-08-31) — Inventory: 13700156000.00
LEN balance_sheet (quarterly, 2025-08-31) — Invested Capital: 27957931000.00
LEN cash_flow (quarterly, 2025-08-31) — Investing Cash Flow: -7247000.00
LEN balance_sheet (quarterly, 2025-08-31) — Investment Properties: 6012493000.00
LEN balance_sheet (quarterly, 2025-08-31) — Investmentin Financial Assets: 419147000.00
LEN balance_sheet (quarterly, 2025-08-31) — Investments And Advances: 3961899000.00
LEN balance_sheet (quarterly, 2025-08-31) — Investments In Other Ventures Under Equity Method: 3542752000.00
LEN cash_flow (quarterly, 2025-08-31) — Issuance Of Debt: 740000000.00
LEN balance_sheet (quarterly, 2025-08-31) — Loans Receivable: 2081628000.00
LEN balance_sheet (quarterly, 2025-08-31) — Long Term Debt: 5387611000.00
LEN balance_sheet (quarterly, 2025-08-31) — Long Term Debt And Capital Lease Obligation: 5387611000.00
LEN cash_flow (quarterly, 2025-08-31) — Long Term Debt Issuance: -400000000.00
LEN cash_flow (quarterly, 2025-08-31) — Long Term Debt Payments: -8330000.00
LEN balance_sheet (quarterly, 2025-08-31) — Long Term Equity Investment: 3542752000.00
LEN balance_sheet (quarterly, 2025-08-31) — Minority Interest: 181235000.00
LEN income_statement (quarterly, 2025-08-31) — Minority Interests: -8844000.00
LEN cash_flow (quarterly, 2025-08-31) — Net Business Purchase And Sale: -57516000.00
LEN cash_flow (quarterly, 2025-08-31) — Net Common Stock Issuance: -512418000.00
LEN balance_sheet (quarterly, 2025-08-31) — Net Debt: 3725398000.00
LEN income_statement (quarterly, 2025-08-31) — Net Income: 590967000.00
LEN income_statement (quarterly, 2025-08-31) — Net Income Common Stockholders: 585719000.00
LEN income_statement (quarterly, 2025-08-31) — Net Income Continuous Operations: 599811000.00
LEN income_statement (quarterly, 2025-08-31) — Net Income From Continuing And Discontinued Operation: 590967000.00
LEN income_statement (quarterly, 2025-08-31) — Net Income From Continuing Operation Net Minority Interest: 590967000.00
LEN cash_flow (quarterly, 2025-08-31) — Net Income From Continuing Operations: 599811000.00
LEN income_statement (quarterly, 2025-08-31) — Net Income Including Noncontrolling Interests: 599811000.00
LEN cash_flow (quarterly, 2025-08-31) — Net Investment Purchase And Sale: 130492000.00
LEN cash_flow (quarterly, 2025-08-31) — Net Issuance Payments Of Debt: 1179377000.00
LEN cash_flow (quarterly, 2025-08-31) — Net Long Term Debt Issuance: -408330000.00
LEN cash_flow (quarterly, 2025-08-31) — Net Other Financing Charges: -93997000.00
LEN cash_flow (quarterly, 2025-08-31) — Net Other Investing Changes: -163251000.00
LEN balance_sheet (quarterly, 2025-08-31) — Net PPE: 15425000.00
LEN cash_flow (quarterly, 2025-08-31) — Net PPE Purchase And Sale: 22638000.00
LEN cash_flow (quarterly, 2025-08-31) — Net Short Term Debt Issuance: 1587707000.00
LEN balance_sheet (quarterly, 2025-08-31) — Net Tangible Assets: 18938262000.00
LEN income_statement (quarterly, 2025-08-31) — Normalized EBITDA: 656144000.00
LEN income_statement (quarterly, 2025-08-31) — Normalized Income: 515954412.00
LEN cash_flow (quarterly, 2025-08-31) — Operating Cash Flow: -158611000.00
LEN cash_flow (quarterly, 2025-08-31) — Operating Gains Losses: -110975000.00
LEN income_statement (quarterly, 2025-08-31) — Operating Income: 721198000.00
LEN income_statement (quarterly, 2025-08-31) — Operating Revenue: 8810278000.00
LEN balance_sheet (quarterly, 2025-08-31) — Ordinary Shares Number: 255020543.00
LEN balance_sheet (quarterly, 2025-08-31) — Other Equity Adjustments: 6019000.00
LEN income_statement (quarterly, 2025-08-31) — Other Gand A: 171397000.00
LEN income_statement (quarterly, 2025-08-31) — Other Income Expense: 69505000.00
LEN balance_sheet (quarterly, 2025-08-31) — Other Inventories: 2581070000.00
LEN cash_flow (quarterly, 2025-08-31) — Other Non Cash Items: -2241000.00
LEN balance_sheet (quarterly, 2025-08-31) — Other Non Current Assets: 2128393000.00
LEN balance_sheet (quarterly, 2025-08-31) — Other Non Current Liabilities: 4797186000.00
LEN income_statement (quarterly, 2025-08-31) — Other Non Operating Income Expenses: -40540000.00
LEN balance_sheet (quarterly, 2025-08-31) — Other Short Term Investments: 39069000.00
LEN income_statement (quarterly, 2025-08-31) — Otherunder Preferred Stock Dividend: 5248000.00
LEN balance_sheet (quarterly, 2025-08-31) — Payables: 1521244000.00
LEN balance_sheet (quarterly, 2025-08-31) — Payables And Accrued Expenses: 1521244000.00
LEN balance_sheet (quarterly, 2025-08-31) — Preferred Stock: 0.00
LEN income_statement (quarterly, 2025-08-31) — Pretax Income: 790703000.00
LEN cash_flow (quarterly, 2025-08-31) — Purchase Of Business: -57516000.00
LEN cash_flow (quarterly, 2025-08-31) — Purchase Of Investment: 0.00
LEN cash_flow (quarterly, 2025-08-31) — Purchase Of PPE: -32165000.00
LEN balance_sheet (quarterly, 2025-08-31) — Receivables: 3631911000.00
LEN income_statement (quarterly, 2025-08-31) — Reconciled Cost Of Revenue: 7917683000.00
LEN income_statement (quarterly, 2025-08-31) — Reconciled Depreciation: 34169000.00
LEN cash_flow (quarterly, 2025-08-31) — Repayment Of Debt: 439377000.00
LEN cash_flow (quarterly, 2025-08-31) — Repurchase Of Capital Stock: -512418000.00
LEN balance_sheet (quarterly, 2025-08-31) — Restricted Cash: 94784000.00
LEN balance_sheet (quarterly, 2025-08-31) — Retained Earnings: 22107836000.00
LEN cash_flow (quarterly, 2025-08-31) — Sale Of Business: 0.00
LEN cash_flow (quarterly, 2025-08-31) — Sale Of Investment: 130492000.00
LEN income_statement (quarterly, 2025-08-31) — Selling General And Administration: 171397000.00
LEN balance_sheet (quarterly, 2025-08-31) — Share Issued: 298131792.00
LEN cash_flow (quarterly, 2025-08-31) — Short Term Debt Payments: 447707000.00
LEN cash_flow (quarterly, 2025-08-31) — Stock Based Compensation: 25505000.00
LEN balance_sheet (quarterly, 2025-08-31) — Stockholders Equity: 22570320000.00
LEN balance_sheet (quarterly, 2025-08-31) — Tangible Book Value: 18938262000.00
LEN income_statement (quarterly, 2025-08-31) — Tax Effect Of Unusual Items: 24210412.00
LEN income_statement (quarterly, 2025-08-31) — Tax Provision: 190892000.00
LEN income_statement (quarterly, 2025-08-31) — Tax Rate For Calcs: 0.24
LEN balance_sheet (quarterly, 2025-08-31) — Total Assets: 34878401000.00
LEN balance_sheet (quarterly, 2025-08-31) — Total Capitalization: 27957931000.00
LEN balance_sheet (quarterly, 2025-08-31) — Total Debt: 5387611000.00
LEN balance_sheet (quarterly, 2025-08-31) — Total Equity Gross Minority Interest: 22751555000.00
LEN income_statement (quarterly, 2025-08-31) — Total Expenses: 8089080000.00
LEN balance_sheet (quarterly, 2025-08-31) — Total Liabilities Net Minority Interest: 12126846000.00
LEN balance_sheet (quarterly, 2025-08-31) — Total Non Current Assets: 15750268000.00
LEN balance_sheet (quarterly, 2025-08-31) — Total Non Current Liabilities Net Minority Interest: 10605602000.00
LEN income_statement (quarterly, 2025-08-31) — Total Unusual Items: 99223000.00
LEN income_statement (quarterly, 2025-08-31) — Total Unusual Items Excluding Goodwill: 99223000.00
LEN balance_sheet (quarterly, 2025-08-31) — Tradeand Other Payables Non Current: 420805000.00
LEN balance_sheet (quarterly, 2025-08-31) — Treasury Shares Number: 43111249.00
LEN balance_sheet (quarterly, 2025-08-31) — Treasury Stock: 5457876000.00
LEN cash_flow (quarterly, 2025-08-31) — Unrealized Gain Loss On Investment Securities: 61105000.00
LEN balance_sheet (quarterly, 2025-08-31) — Working Capital: 17606889000.00
LEN income_statement (annual, 2025-11-30) — +Operating Expense: 636718000.00
LEN income_statement (quarterly, 2025-11-30) — +Operating Expense: 162090000.00
LEN income_statement (annual, 2025-11-30) — +Total Revenue: 34186934000.00
LEN income_statement (quarterly, 2025-11-30) — +Total Revenue: 9367609000.00
LEN balance_sheet (annual, 2025-11-30) — Accounts Payable: 1812484000.00
LEN balance_sheet (quarterly, 2025-11-30) — Accounts Payable: 1812484000.00
LEN balance_sheet (annual, 2025-11-30) — Accounts Receivable: 1310019000.00
LEN balance_sheet (quarterly, 2025-11-30) — Accounts Receivable: 1310019000.00
LEN balance_sheet (annual, 2025-11-30) — Accumulated Depreciation: -315175000.00
LEN balance_sheet (quarterly, 2025-11-30) — Accumulated Depreciation: -315175000.00
LEN balance_sheet (annual, 2025-11-30) — Additional Paid In Capital: 5909726000.00
LEN balance_sheet (quarterly, 2025-11-30) — Additional Paid In Capital: 5909726000.00
LEN balance_sheet (annual, 2025-11-30) — Available For Sale Securities: 346820000.00
LEN balance_sheet (quarterly, 2025-11-30) — Available For Sale Securities: 346820000.00
LEN income_statement (annual, 2025-11-30) — Basic Average Shares: 257746000.00
LEN income_statement (quarterly, 2025-11-30) — Basic Average Shares: 252363000.00
LEN income_statement (annual, 2025-11-30) — Basic EPS: 7.98
LEN income_statement (quarterly, 2025-11-30) — Basic EPS: 1.93
LEN cash_flow (annual, 2025-11-30) — Beginning Cash Position: 4990210000.00
LEN cash_flow (quarterly, 2025-11-30) — Beginning Cash Position: 1756997000.00
LEN cash_flow (annual, 2025-11-30) — Capital Expenditure: -188629000.00
LEN cash_flow (quarterly, 2025-11-30) — Capital Expenditure: -85205000.00
LEN balance_sheet (annual, 2025-11-30) — Capital Stock: 29818000.00
LEN balance_sheet (quarterly, 2025-11-30) — Capital Stock: 29818000.00
LEN balance_sheet (annual, 2025-11-30) — Cash And Cash Equivalents: 3756305000.00
LEN balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 3756305000.00
LEN balance_sheet (annual, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 3795365000.00
LEN balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 3795365000.00
LEN cash_flow (annual, 2025-11-30) — Cash Dividends Paid: -520959000.00
LEN cash_flow (quarterly, 2025-11-30) — Cash Dividends Paid: -126602000.00
LEN cash_flow (annual, 2025-11-30) — Cash Flow From Continuing Financing Activities: -1597856000.00
LEN cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Financing Activities: 268316000.00
LEN cash_flow (annual, 2025-11-30) — Cash Flow From Continuing Investing Activities: 221568000.00
LEN cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Investing Activities: 45934000.00
LEN cash_flow (annual, 2025-11-30) — Cash Flow From Continuing Operating Activities: 216812000.00
LEN cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Operating Activities: 1759487000.00
LEN cash_flow (annual, 2025-11-30) — Change In Account Payable: -690751000.00
LEN cash_flow (quarterly, 2025-11-30) — Change In Account Payable: 287297000.00
LEN cash_flow (annual, 2025-11-30) — Change In Inventory: -150921000.00
LEN cash_flow (quarterly, 2025-11-30) — Change In Inventory: 1164012000.00
LEN cash_flow (annual, 2025-11-30) — Change In Other Current Assets: -62338000.00
LEN cash_flow (quarterly, 2025-11-30) — Change In Other Current Assets: 147554000.00
LEN cash_flow (annual, 2025-11-30) — Change In Payable: -690751000.00
LEN cash_flow (quarterly, 2025-11-30) — Change In Payable: 287297000.00
LEN cash_flow (annual, 2025-11-30) — Change In Payables And Accrued Expense: -690751000.00
LEN cash_flow (quarterly, 2025-11-30) — Change In Payables And Accrued Expense: 287297000.00
LEN cash_flow (annual, 2025-11-30) — Change In Prepaid Assets: -1549664000.00
LEN cash_flow (quarterly, 2025-11-30) — Change In Prepaid Assets: -301274000.00
LEN cash_flow (annual, 2025-11-30) — Change In Receivables: 66764000.00
LEN cash_flow (quarterly, 2025-11-30) — Change In Receivables: -163344000.00
LEN cash_flow (annual, 2025-11-30) — Change In Working Capital: -2386910000.00
LEN cash_flow (quarterly, 2025-11-30) — Change In Working Capital: 1134245000.00
LEN cash_flow (annual, 2025-11-30) — Changes In Cash: -1159476000.00
LEN cash_flow (quarterly, 2025-11-30) — Changes In Cash: 2073737000.00
LEN balance_sheet (annual, 2025-11-30) — Common Stock: 29818000.00
LEN balance_sheet (quarterly, 2025-11-30) — Common Stock: 29818000.00
LEN cash_flow (annual, 2025-11-30) — Common Stock Dividend Paid: -520959000.00
LEN cash_flow (quarterly, 2025-11-30) — Common Stock Dividend Paid: -126602000.00
LEN balance_sheet (annual, 2025-11-30) — Common Stock Equity: 21959417000.00
LEN balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 21959417000.00
LEN cash_flow (annual, 2025-11-30) — Common Stock Payments: -1808369000.00
LEN cash_flow (quarterly, 2025-11-30) — Common Stock Payments: -57000.00
LEN balance_sheet (annual, 2025-11-30) — Construction In Progress: 6398729000.00
LEN balance_sheet (quarterly, 2025-11-30) — Construction In Progress: 6398729000.00
LEN income_statement (annual, 2025-11-30) — Cost Of Revenue: 30799809000.00
LEN income_statement (quarterly, 2025-11-30) — Cost Of Revenue: 8538560000.00
LEN balance_sheet (annual, 2025-11-30) — Current Assets: 19394535000.00
LEN balance_sheet (quarterly, 2025-11-30) — Current Assets: 19394535000.00
LEN balance_sheet (annual, 2025-11-30) — Current Liabilities: 1812484000.00
LEN balance_sheet (quarterly, 2025-11-30) — Current Liabilities: 1812484000.00
LEN cash_flow (annual, 2025-11-30) — Deferred Income Tax: 77295000.00
LEN cash_flow (quarterly, 2025-11-30) — Deferred Income Tax: -37000.00
LEN cash_flow (annual, 2025-11-30) — Deferred Tax: 77295000.00
LEN cash_flow (quarterly, 2025-11-30) — Deferred Tax: -37000.00
LEN cash_flow (annual, 2025-11-30) — Depreciation Amortization Depletion: 134310000.00
LEN cash_flow (quarterly, 2025-11-30) — Depreciation Amortization Depletion: 34984000.00
LEN cash_flow (annual, 2025-11-30) — Depreciation And Amortization: 134310000.00
LEN cash_flow (quarterly, 2025-11-30) — Depreciation And Amortization: 34984000.00
LEN income_statement (annual, 2025-11-30) — Diluted Average Shares: 257746000.00
LEN income_statement (quarterly, 2025-11-30) — Diluted Average Shares: 252363000.00
LEN income_statement (annual, 2025-11-30) — Diluted EPS: 7.98
LEN income_statement (quarterly, 2025-11-30) — Diluted EPS: 1.93
LEN income_statement (annual, 2025-11-30) — Diluted NI Availto Com Stockholders: 2058083000.00
LEN income_statement (quarterly, 2025-11-30) — Diluted NI Availto Com Stockholders: 486497000.00
LEN cash_flow (annual, 2025-11-30) — Dividend Received Cfo: 36578000.00
LEN cash_flow (quarterly, 2025-11-30) — Dividend Received Cfo: 8312000.00
LEN cash_flow (annual, 2025-11-30) — Dividends Received Cfi: 281536000.00
LEN cash_flow (quarterly, 2025-11-30) — Dividends Received Cfi: 45943000.00
LEN income_statement (annual, 2025-11-30) — EBIT: 2750407000.00
LEN income_statement (quarterly, 2025-11-30) — EBIT: 666959000.00
LEN income_statement (annual, 2025-11-30) — EBITDA: 2884717000.00
LEN income_statement (quarterly, 2025-11-30) — EBITDA: 701943000.00
LEN income_statement (annual, 2025-11-30) — Earnings From Equity Interest: 78225000.00
LEN income_statement (quarterly, 2025-11-30) — Earnings From Equity Interest: 22053000.00
LEN cash_flow (annual, 2025-11-30) — Earnings Losses From Equity Investments: -78225000.00
LEN cash_flow (quarterly, 2025-11-30) — Earnings Losses From Equity Investments: -22053000.00
LEN cash_flow (annual, 2025-11-30) — End Cash Position: 3830734000.00
LEN cash_flow (quarterly, 2025-11-30) — End Cash Position: 3830734000.00
LEN cash_flow (annual, 2025-11-30) — Financing Cash Flow: -1597856000.00
LEN cash_flow (quarterly, 2025-11-30) — Financing Cash Flow: 268316000.00
LEN balance_sheet (annual, 2025-11-30) — Finished Goods: 9921232000.00
LEN balance_sheet (quarterly, 2025-11-30) — Finished Goods: 9921232000.00
LEN cash_flow (annual, 2025-11-30) — Free Cash Flow: 28183000.00
LEN cash_flow (quarterly, 2025-11-30) — Free Cash Flow: 1674282000.00
LEN cash_flow (annual, 2025-11-30) — Gain Loss On Investment Securities: 183702000.00
LEN cash_flow (quarterly, 2025-11-30) — Gain Loss On Investment Securities: 193995000.00
LEN cash_flow (annual, 2025-11-30) — Gain Loss On Sale Of Business: 156076000.00
LEN cash_flow (quarterly, 2025-11-30) — Gain Loss On Sale Of Business: 191754000.00
LEN cash_flow (annual, 2025-11-30) — Gain Loss On Sale Of PPE: -77737000.00
LEN cash_flow (quarterly, 2025-11-30) — Gain Loss On Sale Of PPE: -43651000.00
LEN income_statement (annual, 2025-11-30) — Gain On Sale Of Security: 130166000.00
LEN income_statement (quarterly, 2025-11-30) — Gain On Sale Of Security: 122886000.00
LEN balance_sheet (annual, 2025-11-30) — Gains Losses Not Affecting Retained Earnings: 6011000.00
LEN balance_sheet (quarterly, 2025-11-30) — Gains Losses Not Affecting Retained Earnings: 6011000.00
LEN income_statement (annual, 2025-11-30) — General And Administrative Expense: 636718000.00
LEN income_statement (quarterly, 2025-11-30) — General And Administrative Expense: 162090000.00
LEN balance_sheet (annual, 2025-11-30) — Goodwill: 3632058000.00
LEN balance_sheet (quarterly, 2025-11-30) — Goodwill: 3632058000.00
LEN balance_sheet (annual, 2025-11-30) — Goodwill And Other Intangible Assets: 3632058000.00
LEN balance_sheet (quarterly, 2025-11-30) — Goodwill And Other Intangible Assets: 3632058000.00
LEN balance_sheet (annual, 2025-11-30) — Gross PPE: 7356742000.00
LEN balance_sheet (quarterly, 2025-11-30) — Gross PPE: 7356742000.00
LEN income_statement (annual, 2025-11-30) — Gross Profit: 3387125000.00
LEN income_statement (quarterly, 2025-11-30) — Gross Profit: 829049000.00
LEN balance_sheet (annual, 2025-11-30) — Held To Maturity Securities: 132868000.00
LEN balance_sheet (quarterly, 2025-11-30) — Held To Maturity Securities: 132868000.00